Myoepithelial sialadenitis versus low-grade non-Hodgkin's lymphoma of the salivary gland in FNAB: Is discrimination by means of an image processing system possible?

被引:0
作者
Ruschenburg, I
Kneitz, S
Brinck, U
Korabiowska, M
Harms, H
Droese, M
机构
[1] Univ Gottingen, Dept Cytopathol, D-37075 Gottingen, Germany
[2] Univ Wurzburg, Inst Virol & Immunbiol, Biomed Image Proc Res Lab, D-97070 Wurzburg, Germany
[3] Univ Gottingen, Dept Gastroenteropathol, D-3400 Gottingen, Germany
来源
IN VIVO | 1999年 / 13卷 / 06期
关键词
myoepithelial sialadenitis; non-Hodgkin's lymphoma; texture feature analysis; image processing system;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The diagnosis of myoepithelial sialadenitis (MESA) in fine needle aspiration biopsy may be difficult. There is a dense lymphocytic infiltration in the gland and discrimination between a hyperimmune reaction and a low grade non-Hodgkin's lymphoma (NHL) of B-cell origin may be impossible. To get additional diagnostically helpful criteria, texture feature analysis on routinely obtained FNAB's of the salivary gland was applied. In the data set 36/36 cases of low grade B-NHL confirmed by histology and 10/13 histologically confirmed cases of MESA could be classified correctly by means of an image processing system. The chromatin structure of each nucleus was classified by texture features (n=6), which were determined according to the method of Harms er al. For statistical analysis of the cell types a classification tree based on the commercial program CART was applied The data set of 49 cases was proved by the crossvalidation test 10 fold. The calculated diagnosis for each case suggests that this method may be helpful in the cytologically doubtful cases.
引用
收藏
页码:515 / 518
页数:4
相关论文
共 25 条
  • [1] Differentiation of low grade non-Hodgkin's lymphoma by digital image processing
    Kneitz, S
    Ott, G
    Albert, R
    Schindewolf, T
    MullerHermelink, HK
    Harms, H
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1996, 18 (02): : 121 - 128
  • [2] Bexxar®:: Novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma
    Vose, JM
    ONCOLOGIST, 2004, 9 (02) : 160 - 172
  • [3] Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma
    Killick, S
    Mercieca, J
    Nandi, A
    Behrens, J
    CLINICAL AND LABORATORY HAEMATOLOGY, 1997, 19 (01): : 79 - 80
  • [4] Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma
    Misgeld, E
    Germing, U
    Aul, C
    Gattermann, N
    LEUKEMIA RESEARCH, 2001, 25 (01) : 95 - 98
  • [5] Cytomegalovirus retinitis and low-grade non-Hodgkin's lymphoma: Case report and review of the literature
    Derzko-Dzulynsky, LA
    Berger, AR
    Berinstein, NL
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (03) : 228 - 232
  • [6] Primary cervical epidural low-grade non-hodgkin's lymphoma: A case report and review of the literature
    Ben Salah, H. Lahiani
    Daoud, J.
    CANCER RADIOTHERAPIE, 2008, 12 (08): : 863 - 866
  • [7] Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
    Lazzarino, R
    Orlandi, E
    Montillo, M
    Tedeschi, A
    Pagnucco, C
    Astori, C
    Corso, A
    Brusamolino, E
    Simoncini, L
    Morra, E
    Bernasconi, C
    ANNALS OF ONCOLOGY, 1999, 10 (01) : 59 - 64
  • [8] Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
    Tondini, C
    Balzarotti, M
    Rampinelli, I
    Valagussa, P
    Luoni, M
    De Paoli, A
    Santoro, A
    Bonadonna, G
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 231 - 233
  • [9] Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin's lymphoma
    Mijovic, A
    Parker, J
    Salisbury, J
    Pagliuca, A
    Mufti, GJ
    CANCER RESEARCH THERAPY & CONTROL, 1998, 5 (03): : 161 - 169
  • [10] Acute liver failure as initial manifestation of low-grade non-Hodgkin's lymphoma transformation into large-cell lymphoma
    Yeshurun, M
    Isnard, F
    Garderet, L
    Rambeloarisoa, J
    Prevot, S
    Carbonell, N
    Najman, A
    LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 555 - 559